New Wave Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

New Wave Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$778K	Buy	1,247 +354	+40%	+$241K	0.21%	104
2026 Q1	$690K	Buy	893 +297	+50%	+$227K	0.24%	79
2025 Q4	$460K	Buy	596 +71	+14%	+$48.2K	0.17%	97
2025 Q3	$295K	Buy	+525	New	+$297K	0.12%	127
2024 Q4	–	Sell	-353	Closed	-$371K	–	713
2024 Q3	$371K	Sell	353 -13	-4%	-$14.5K	0.17%	88
2024 Q2	$385K	Buy	+366	New	+$355K	0.21%	76

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return

New Wave Wealth Advisors's REGN Position: Q2 2026 in Review

New Wave Wealth Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 40% in Q2 2026, buying an estimated $241K and bringing the position to 1,247 shares worth $778K. The position accounts for 0.21% of the portfolio, ranked #104.

New Wave Wealth Advisors first reported a position in REGN in Q2 2024 and has held it in 6 quarters since. 417 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

New Wave Wealth Advisors held 1,247 shares of Regeneron Pharmaceuticals worth $778K as of Q2 2026.
New Wave Wealth Advisors bought 354 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $241K.
Regeneron Pharmaceuticals made up 0.21% of New Wave Wealth Advisors's portfolio in Q2 2026, its #104 holding.
New Wave Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
417 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on New Wave Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.